Blueberries Medical Corp. (BBM.CN)
| Previous Close | 0.0150 |
| Open | 0.0150 |
| Bid | 0.0100 x 0 |
| Ask | 0.0150 x 0 |
| Day's Range | 0.0150 - 0.0150 |
| 52 Week Range | 0.0050 - 0.0400 |
| Volume | |
| Avg. Volume | 46,972 |
| Market Cap | 5.985M |
| Beta (5Y Monthly) | 1.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | May 28, 2024 - Jun 03, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireBlueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement consisting of the sale of 180,716,00 common shares (“Common Shares”) at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1,987,876 (or approximately US$1,250,000) (the “Offering”). The net proceed
- GlobeNewswire
Blueberries Medical Announces C$2 Million Non-Brokered Private Placement
TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement consisting of the sale of 180,716,000 common shares (“Common Shares”) at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1,987,876 (or approximately US$1,250,000) (the “Offering”). The net procee
- GlobeNewswire
Blueberries Medical Reports Q1-2023
Financial Results, Expands Deals, Achieves Revenue Growth, Enhances Cost Efficiency, and Announces Board and Executive UpdatesTORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), a leading player in the cannabis industry (together the “Company” or "Blueberries") is thrilled to announce its exceptional financial and business performance for the first quarter ended March 31, 2023. The company has
